Cargando…

Editorial: Molecules Balancing Immunological Surveillance against Cancer and Autoimmune Diseases

Detalles Bibliográficos
Autor principal:	Sharabi, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828963/ https://www.ncbi.nlm.nih.gov/pubmed/27148478 http://dx.doi.org/10.3389/fonc.2016.00086

Ejemplares similares

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: Immunologic Mechanisms of Myeloid Neoplasms
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Editorial: Immunotherapy for Prostate Cancer – turning the immunological desert into an oasis of hope
por: Galustian, Christine, et al.
Publicado: (2022)

Editorial: Molecules of the extracellular matrix as cancer targets
por: Karamanos, Nikos K., et al.
Publicado: (2022)

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy
por: Seiffert, Martina, et al.
Publicado: (2022)

Editorial: Adhesion molecules and autoimmune diseases
por: Fan, Zhichao, et al.
Publicado: (2022)

Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells
por: Thakur, Gargi, et al.
Publicado: (2019)

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Disease Biology and Signaling
por: Paggetti, Jérôme, et al.
Publicado: (2021)

Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?
por: Thomas, Juvin Ann, et al.
Publicado: (2023)

Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases
por: Sun, Dao-Ping, et al.
Publicado: (2021)

Editorial: Therapeutic antibody domains against cancer
por: Zhao, Qi, et al.
Publicado: (2023)

Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis
por: Pellegrino, Benedetta, et al.
Publicado: (2020)

Editorial: The Role of Nuclear Molecules in the Pathogenesis of Autoimmune Disease
por: Pisetsky, David S., et al.
Publicado: (2021)

Targeting Opposing Immunological Roles of the Junctional Adhesion Molecule-A in Autoimmunity and Cancer
por: Bonilha, Caio S., et al.
Publicado: (2020)

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Prognostic and Predictive Biomarkers and Therapy
por: Moussay, Etienne, et al.
Publicado: (2022)

Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control
por: Pyo, Kyoung-Ho, et al.
Publicado: (2023)

Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials
por: Gadalla, Ramy, et al.
Publicado: (2019)

The Identification of Immunological Biomarkers in Kidney Cancers
por: Lopez-Beltran, Antonio, et al.
Publicado: (2018)

Immunological Effects of Histotripsy for Cancer Therapy
por: Hendricks-Wenger, Alissa, et al.
Publicado: (2021)

Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases
por: Kubiatowski, Tomasz, et al.
Publicado: (2020)

Editorial: Targeting cancer cell intracellular metabolism as a strategy against therapy resistance
por: Liu, Lingling, et al.
Publicado: (2023)

Editorial: ADAM10 in Cancer Immunology and Autoimmunity: More Than a Simple Biochemical Scissor
por: Rossello, Armando, et al.
Publicado: (2020)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
por: Shindiapina, Polina, et al.
Publicado: (2020)

Editorial: Immunology of Psoriatic Disease
por: Reali, Eva, et al.
Publicado: (2019)

The Efficacy and Safety of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease
por: Tang, Hui, et al.
Publicado: (2021)

Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
por: Brown, Rikki A. M., et al.
Publicado: (2020)

Prognostic and Immunological Role of Gasdermin E in Pan-Cancer Analysis
por: Zhang, Zheng, et al.
Publicado: (2021)

Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer
por: Saiz-Ladera, Cristina, et al.
Publicado: (2021)

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
por: Zhang, Wenxiang, et al.
Publicado: (2021)

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
por: Lv, Wenming, et al.
Publicado: (2022)

Alternative splicing event associated with immunological features in bladder cancer
por: Yu, Xinbo, et al.
Publicado: (2023)

Tipping the balance in autoimmune disease
por: Collins, Mary
Publicado: (2007)

Editorial: Pathophysiological Interrelationship Between Obesity, Metabolic Diseases, and Cancer
por: Gahete, Manuel D., et al.
Publicado: (2021)

Editorial: Cancer Models
por: Breitenbach, Michael, et al.
Publicado: (2018)

Editorial: Cancer Ecosystems
por: Martinez-Outschoorn, Ubaldo E., et al.
Publicado: (2019)

Introduction to immunology and autoimmunity.
por: Smith, D A, et al.
Publicado: (1999)

Cancer and Autoimmune Diseases: A Tale of Two Immunological Opposites?
por: Elkoshi, Zeev
Publicado: (2022)

Editorial: Discovery of small molecule lead compounds: A driving force to unravel new anticancer targets and mechanisms
por: Zhang, Yan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mqgp021tvl18e6q6q6s6s3e1k4